Delivery of a Drug for Medical Use (Durvalumab) for the Needs of the Gb "Okod

RussiaTenders notice for Delivery of a Drug for Medical Use (Durvalumab) for the Needs of the Gb "Okod. The reference ID of the tender is 115340260 and it is closing on 03 Mar 2025.

100% Secure Payments

Tender Details

  • Country: Russia
  • Summary: Delivery of a Drug for Medical Use (Durvalumab) for the Needs of the Gb "Okod
  • RUT Ref No: 115340260
  • Deadline: 03 Mar 2025
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: 1025475.00
  • Notice Type: Tender
  • Document Ref. No.: 0328200001725000005
  • Purchaser's Detail :
  • Purchaser : STATE BUDGETARY INSTITUTION OF HEALTH OF THE VLADIMIR REGION "REGIONAL CLINICAL ONCOLOGICAL DISPENSARY
    Location: Russian Federation, 600009, Vladimir region, Vladimir G, st. Kamanina, d.21
    responsible official: Zyuzkova Svetlana Aleksandrovna
    Number of Contact Phones / Fax: 7-4922-40465-0 / 7-4922-404608
    Email :torgi@onko33.ru

  • Description :
  • Delivery of a drug for medical use (durvalumab) for the needs of the gb "Okod
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
RussiaTenders Features

RussiaTenders Features

Fresh and verified Tenders from Russia. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Russia in your email inbox.

  Chat with us